Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2007-05-14
2010-02-23
Bertoglio, Valarie (Department: 1632)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C424S093200, C424S093210
Reexamination Certificate
active
07666852
ABSTRACT:
The present disclosure provides nucleic acid constructs encoding one or more polypeptides containing at least one glycosaminoglycan chain, such as, but not limited to, a proteoglycan polypeptide, and methods for delivering to the site of a wound or cutaneous injury at least one nucleic acid construct encoding one or more such polypeptides, such that the expressed polypeptide is glycated by glycosaminoglycan chains through the normal physiological processes of the subject at the site of administration to produce a functional proteoglycan polypeptide for the healing of the wound or other cutaneous injury. The delivered nucleic acid construct is transcribed, translated and post-translationally modified by the addition of glycosaminoglycan chains (referred herein as “decoration” or “glycation”) to produce a decorated polypeptide. The decorated polypeptide is then secreted from the cell in which it was produced to provide treatment of wounds and/or cutaneous injury in the subject and/or prevention of cutaneous injury in a subject.
REFERENCES:
patent: 6524573 (2003-02-01), Iozzo
patent: 7029668 (2006-04-01), Simons
patent: 7141551 (2006-11-01), DeCarlo
patent: 9906054 (1999-02-01), None
patent: 0217955 (2002-03-01), None
Crombleholme, 2008, Wound Repair and Regeneration, 8:460-472.
International Search Report, PCT/US2008/006139, May 14, 2008.
Groffen et al., Expression and Characterization of Human Perlecan Domains I and II Synthesized by Baculovirus-Infected Insect Cells. Eur. J. Biochem. 241, pp. 827-834.
Nugent et al., Fibroblast Growth Factor-2. International J. Biochem. Cell Viol. 2000, vol. 32 pp. 115-120.
Zhao et al., Adenovirus-Mediated Decorin Gene Transfer Prevents TGF-Beta Induced Inhibition of Lung Morphogenesis. American Physiological Society. vol. 277 (Lung Cell. Mol. Phys.21) pp. L412-L422.
Decarlo Arthur A.
Ellis April L.
Whitelock John
Agenta Biotechnologies, Inc.
Bertoglio Valarie
Bradley Arant Boult Cummings, LLP.
Peterson T. Gregory
LandOfFree
Wound and cutaneous injury healing with a nucleic acid... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Wound and cutaneous injury healing with a nucleic acid..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Wound and cutaneous injury healing with a nucleic acid... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4207810